Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3Breast Neoplasms 3Prostatic Neoplasms 2Neuroblastoma 2Melanoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia 2Endometrial Neoplasms 2Congenital Abnormalities 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Pleuropulmonary blastoma 1Papillomavirus Infections 1Pain 1Neurofibrosarcoma 1Neoplasms 1Myeloproliferative Syndrome, Transient 1Meningioma 1Malignant mesenchymal tumor 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Liposarcoma 1Leukemia, Eosinophilic, Acute 1

Interventions

lorvotuzumab mertansine 1Watchful Waiting 1Vincristine 1Topotecan 1Specimen Handling 1Razoxane 1Polymerase Chain Reaction 1Observation 1Magnetic Resonance Spectroscopy 1Ifosfamide 1High-Energy Shock Waves 1Gene Rearrangement 1Gene Expression Profiling 1Doxorubicin 1Dexrazoxane 1Dactinomycin 1Cytogenetic Analysis 1Cyclophosphamide 1Amplified Fragment Length Polymorphism Analysis 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Pleuropulmonary blastoma × Observation × Clear all
NCT06647953 2026-05-05

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Children's Oncology Group

Phase 3 Recruiting
110 enrolled

Pleuropulmonary blastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡